Bayer lost an attempt to continue sales of flubendiamide, marketed in the United States as Belt, after the EPA earlier found that it posed risks to the environment. An EPA board, however, ruled that farmers and retailers will be allowed to use their existing supplies of the chemical, Bayer said in a statement. The EPA could not be reached for comment after normal... » Read More
Dow Chemical and Rohm & Haas, which will face off in a Delaware court next Monday to determine Dow's $78 cash deal to acquire Rohm & Haas, are engaged in talks to find a resolution to their dispute, CNBC has learned.
Plus, Cramer extends an invitation to Pepsi’s Indra Nooyi, talks technicals and makes a call on Dow Chemical.
It's amazing how much damage one man can do in such a short period of time.
Who among Bernie’s $50 billion worth of investors should get their money back? And what if some were in on the scam?
Mortgage rates are falling, a housing bottom looks near, oil's at $34, and GM lives to see another day.
With an unsafe dividend, exposure to slowing industries and that big run in a very short time, Cramer thinks this stock is a sell.
This is the sector to own, but not just any stock will do. Find out which name is Mad Money's favorite.
A big dividend makes this stock a buy, buy, buy.
U.S. companies ranging from chemicals like Du Pont, to pharmas like Pfizer and Schering Plough, and financials like Fifth Third and BlackRock, reported earnings Tuesday.
European earnings were mixed Thursday, with telecoms reporting results in line or above forecasts, while energy companies and financials posted profit declines or figures below market expectations.
Dow Chemical posted second-quarter earnings that fell short of market expectations as its price increases did not completely offset a sharp spike in energy and raw material costs.
Chemical maker DuPont Tuesday posted higher-than-expected quarterly earnings as strong demand for its corn and soybean seeds offset weakness in the domestic housing and automotive markets.
A flurry of consolidation in the industry has Cramer predicting what could be next to go.
Ashland, which makes chemicals and Valvoline motor oil, said on Friday that it would acquire Hercules in a $2.6 billion cash-and-stock deal that would significantly boost its product offerings.
Warren Buffett's Berkshire Hathaway is helping to finance Dow's just-announced deal to buy specialty chemical maker Rohm and Haas for over $15 billion in cash. Berkshire is contributing an equity investment in the form of $3 billion worth of convertible preferred securities. The Kuwait Investment Authority is also making a $1 billion investment.
This company's making moves to increase its market footprint while reducing the carbon one we leave behind.
Dow Chemical, the biggest U.S. chemical manufacturer, said on Wednesday it would hike prices for all its products by up to 20 percent next month, the latest signal that escalating energy prices were stoking inflation.
Chief executives from around Europe discussed their companies' earnings, opportunities and the challenges they face in 2008 with CNBC Europe Wednesday.
Commerzbank had the most disappointing earnings results out of Europe Wednesday, as the German bank's first-quarter net profit fell 54 percent and it announced a 244 million euro ($377.9 million) writedown.
The company's genetically modified seeds are just what the world needs.